Unknown

Dataset Information

Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA).


ABSTRACT:

Background

Spinal muscular atrophy (SMA) is a rare, progressive neuromuscular disease that affects individuals with a broad age range. SMA is typically characterised by symmetrical muscle weakness but is also associated with cardiac defects, life-limiting impairments in respiratory function and bulbar function defects that affect swallowing and speech. Despite the advent of three innovative disease-modifying therapies (DMTs) for SMA, the cost of DMTs in addition to the costs of standard of care can be a barrier to treatment access for patients. Health Technology Assessment (HTA) decision makers evaluate the cost effectiveness of a new treatment before making a reimbursement decision.

Objective

The primary objective was to conduct a systematic literature review (SLR) to ident

SUBMITTER: Paracha N 

PROVIDER: S-EPMC8994739 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature